Enhanced tumor control activities of anti-mPD-L1 antibody and antigen-presenting cell-like natural killer cell in an allograft model
Abstract Background Despite the utilization of immune checkpoint inhibitors (ICIs) in treating numerous types of cancers being approved, their efficacy in tumor control in the clinic is not satisfactory. Since adoptive cell therapy (ACT) can alter the tumor microenvironment, we hypothesized that ACT...
Main Authors: | Yi-Ping Hung, Chia-Chun Tu, Jiun-I Lai, Muh-Hwa Yang, Jan-Mou Lee, Yee Chao |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-01-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-024-11889-4 |
Similar Items
-
The Immune Checkpoint PD-1 in Natural Killer Cells: Expression, Function and Targeting in Tumour Immunotherapy
by: Linda Quatrini, et al.
Published: (2020-11-01) -
Emerging predictive biomarkers for novel therapeutics in peripheral T-cell and natural killer/T-cell lymphoma
by: Daniel Ren Yi Yap, et al.
Published: (2023-01-01) -
Simultaneous Genetic Ablation of PD-1, LAG-3, and TIM-3 in CD8 T Cells Delays Tumor Growth and Improves Survival Outcome
by: Elisa Ciraolo, et al.
Published: (2022-03-01) -
Functional crosstalk and regulation of natural killer cells in tumor microenvironment: Significance and potential therapeutic strategies
by: Liping Wang, et al.
Published: (2023-05-01) -
Combined PD-L1 and TIM3 blockade improves expansion of fit human CD8+ antigen-specific T cells for adoptive immunotherapy
by: Shirin Lak, et al.
Published: (2022-12-01)